TGen to Partner with Asuragen on Cancer Dx

The collaborators will use Asuragen's microRNA technologies to identify potential biomarkers for use in pancreatic cancer diagnostic tests.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories